Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
ARAF (A-Raf Proto-Oncogene)
i
Other names:
ARAF, A-Raf Proto-Oncogene, Serine/Threonine Kinase, V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog 1, Serine/Threonine-Protein Kinase A-Raf, Proto-Oncogene A-Raf-1, Proto-Oncogene Pks, ARAF1, PKS2, V-Raf Murine Sarcoma 3611 Viral Oncogene-Like Protein, A-Raf Proto-Oncogene Serine/Threonine-Protein Kinase, Ras-Binding Protein DA-Raf, Proto-Oncogene A-Raf, Oncogene ARAF1, A-RAF, RAFA1, PKS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
369
Related tests:
‹
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
Tempus xT Assay (1)
Labcorp® Plasma Complete™
Neo Comprehensive - Myeloid Disorders Assay
NeoLAB® Solid Tumor Liquid Biopsy
NexCourse®
Northstar Select™
OncoGuide™ NCC Oncopanel System
Oncomine Precision Assay
Tempus xF Assay
TheraMap Test
oncoReveal™ Core LBx
oncoReveal™ Solid Tumor v2 Panel
Guardant360® CDx (54)
FoundationOne® Liquid CDx (21)
Guardant360 TissueNext™ (2)
Oncomine™ Comprehensive Assay v3M (2)
Tempus xT Assay (1)
Labcorp® Plasma Complete™
Neo Comprehensive - Myeloid Disorders Assay
NeoLAB® Solid Tumor Liquid Biopsy
NexCourse®
Northstar Select™
OncoGuide™ NCC Oncopanel System
Oncomine Precision Assay
Tempus xF Assay
TheraMap Test
oncoReveal™ Core LBx
oncoReveal™ Solid Tumor v2 Panel
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
ARAF S214C
Lung Adenocarcinoma
ARAF S214C
Lung Adenocarcinoma
sorafenib
Sensitive: C4 – Case Studies
sorafenib
Sensitive
:
C4
sorafenib
Sensitive: C4 – Case Studies
sorafenib
Sensitive
:
C4
ARAF Q489L
Colorectal Cancer
ARAF Q489L
Colorectal Cancer
trametinib + dabrafenib
Resistant: C4 – Case Studies
trametinib + dabrafenib
Resistant
:
C4
trametinib + dabrafenib
Resistant: C4 – Case Studies
trametinib + dabrafenib
Resistant
:
C4
ARAF mutation + NRAS mutation
Melanoma
ARAF mutation + NRAS mutation
Melanoma
RG6185
Resistant: D – Preclinical
RG6185
Resistant
:
D
RG6185
Resistant: D – Preclinical
RG6185
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.